Corbus Pharmaceuticals Holdings, Inc. — Balance Sheet Charts
42 snapshots of history · ending 2024-09-30 · SEC EDGAR
Source:10-K · 10-Q
Assets vs Liabilities
Cash Position Breakdown
Debt Structure
Working Capital Components
Capital Structure (LT Debt / Cash / Equity)
Total Assets↑+352.5% +$128M
$164M
Current Assets↑+415.6% +$130M
$161M
Cash & Equivalents↑+72.7% +$8M
$19M
ST Investments↑+700.4% +$122M
$140M
Net PPE↓-53.7% -$602K
$519K
Total Liabilities↓-62.0% -$22M
$14M
Current Liabilities↓-63.1% -$20M
$12M
Account Payables↓-38.8% -$2M
$3M
Long-Term Debt↓-100.0% -$22M
$0
Stockholders Equity↑+48136.5% +$150M
$150M
Retained Earnings↓-9.0% -$39M
$-467M
Operating Lease ROU Asset↓-27.5% -$901K
$2M
Operating Lease Liability↓-27.9% -$1M
$4M
Gross PP&E↑+0.0% +$454
$5M
Accumulated Depreciation↑+17.7% +$602K
$4M
Debt Due Y1↑+391.4% +$12M
$15M
Debt Due Y2↑+114.6% +$10M
$18M
Debt Due Y3↓-16.0% -$2M
$8M
Debt Due Y4
$8M
Total Debt Carrying Amount↓-100.0% -$18M
$0
Contract Asset↑+160.4% +$2M
$3M
Contract Liability
$2M
Contract Liability (Current)
$2M